Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yashiro M et al. – The inhibition of lymphangiogenesis targeting VEGFR–3 phosphorylation is a therapeutic strategy for inhibiting LN metastasis of diffuse–type gastric cancer.

Related Articles

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease
Expert Review of Neurotherapeutics, 11/19/09    Relevance Score: 93%

Phosphorylation status of nephrin in human membranous nephropathy
Clinical and Experimental Nephrology, 11/06/09    Relevance Score: 89%

Differential phosphorylation of the docking protein Gab1 by c-Src and the hepatocyte growth factor receptor regulates different aspects of cell functions
Oncogene, 11/05/09    Relevance Score: 88%

Phosphorylation regulates human T-cell leukemia virus type 1 Rex function
Retrovirology, 11/18/09    Relevance Score: 87%

Blockade of Hsp20 Phosphorylation Exacerbates Cardiac Ischemia/Reperfusion Injury by Suppressed Autophagy and Increased Cell Death
Circulation Research, 11/03/09    Relevance Score: 87%

Today in GI Oncology...keeping you current

Is temperature an effect modifier of the association between green tea intake and gastric cancer risk
European Journal of Cancer Prevention, 12/08/09

Detection of Treatment-Induced Changes in Signaling Pathways in Gastrointestinal Stromal Tumors Using Transcriptomic Data
Cancer Research, 12/08/09

Job strain and risk of esophageal and cardia cancers
Cancer Epidemiology, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address